Correlation Between HCW Biologics and Adverum Biotechnologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both HCW Biologics and Adverum Biotechnologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HCW Biologics and Adverum Biotechnologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HCW Biologics and Adverum Biotechnologies, you can compare the effects of market volatilities on HCW Biologics and Adverum Biotechnologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HCW Biologics with a short position of Adverum Biotechnologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of HCW Biologics and Adverum Biotechnologies.

Diversification Opportunities for HCW Biologics and Adverum Biotechnologies

0.25
  Correlation Coefficient

Modest diversification

The 3 months correlation between HCW and Adverum is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding HCW Biologics and Adverum Biotechnologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adverum Biotechnologies and HCW Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HCW Biologics are associated (or correlated) with Adverum Biotechnologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adverum Biotechnologies has no effect on the direction of HCW Biologics i.e., HCW Biologics and Adverum Biotechnologies go up and down completely randomly.

Pair Corralation between HCW Biologics and Adverum Biotechnologies

Given the investment horizon of 90 days HCW Biologics is expected to generate 3.11 times more return on investment than Adverum Biotechnologies. However, HCW Biologics is 3.11 times more volatile than Adverum Biotechnologies. It trades about 0.02 of its potential returns per unit of risk. Adverum Biotechnologies is currently generating about 0.01 per unit of risk. If you would invest  180.00  in HCW Biologics on November 19, 2024 and sell it today you would lose (140.00) from holding HCW Biologics or give up 77.78% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

HCW Biologics  vs.  Adverum Biotechnologies

 Performance 
       Timeline  
HCW Biologics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days HCW Biologics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Adverum Biotechnologies 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Adverum Biotechnologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

HCW Biologics and Adverum Biotechnologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with HCW Biologics and Adverum Biotechnologies

The main advantage of trading using opposite HCW Biologics and Adverum Biotechnologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HCW Biologics position performs unexpectedly, Adverum Biotechnologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adverum Biotechnologies will offset losses from the drop in Adverum Biotechnologies' long position.
The idea behind HCW Biologics and Adverum Biotechnologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated